Lactobacillus acidophilus probiotics market

Lactobacillus Acidophilus Probiotics Market, by Form (Solid and Liquid), by Application (Food and Beverages, Dietary Supplements, Animal Feed, Pharmaceuticals, and Others), by Distribution Channel (Online Pharmacy, Retail Pharmacy, Hospital Pharmacy, and Supermarket/Hypermarket), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030

Request Free Sample

Nov 2022
CMI5369
182 Pages
Excel & Pdf
Pharmaceutical

Summary

Live microorganisms called probiotics are meant to improve one's health when ingested or applied topically. They can be found in yogurt and other fermented foods, dietary supplements, and beauty products. Although bacteria and other microorganisms are frequently perceived as harmful ‘germs’, many of them are beneficial. Some bacteria produce vitamins and some help to break down disease-causing cells, or aid in food digestion. Many of the microorganisms found in probiotic products are identical to or closely related to those found in human body naturally. Probiotics may contain a variety of microorganisms. The most common are bacteria that belong to groups called Lactobacillus and Bifidobacterium.

Global lactobacillus acidophilus probiotics market is estimated to be valued at US$ 1,499.7 million in 2022 and is expected to exhibit a CAGR of 8.0 % during the forecast period (2022-2030).

Figure 1. Global Lactobacillus Acidophilus Probiotics Market Share (%), by Application, 2022

Global Lactobacillus Acidophilus Probiotics Market- Drivers

The increasing initiatives by several non-government organizations to spread awareness about the use of probiotics is expected to drive the global lactobacillus acidophilus probiotics market growth. For instance, on August 24, 2022, SRM University and Probiotic Science Foundation (India), a non-profit organization, organized the first-ever “Probiotics Awareness Day” in Sonipat, to spread the awareness about health benefits of probiotics.

Moreover, an increase in the prevalence of gastrointestinal diseases is expected to provide lucrative growth to the lactobacillus acidophilus probiotics market over the forecast period. For instance, according to an article published by the National Library of Medicine, in 2021, titled “Burden and Cost of Gastrointestinal, Liver, and Pancreatic Diseases in the U.S.,” there were more than 36.8 million cases of gastrointestinal symptoms and 43.4 million ambulatory visits with a primary gastrointestinal diagnosis, in 2020. Hospitalizations for a principal gastrointestinal diagnosis accounted for more than 3.8 million admissions, with 403,699 readmissions. Gastrointestinal diseases are responsible for millions of healthcare encounters and hundreds of thousands of deaths that annually cost billions of dollars in the U.S.

Lactobacillus Acidophilus Probiotics Market Report Coverage

Report Coverage	Details
Base Year:	2021	Market Size in 2022:	US$ 1,499.7 Mn
Historical Data for:	2017 to 2020	Forecast Period:	2022 to 2030
Forecast Period 2022 to 2030 CAGR:	8.0 %	2030 Value Projection:	US$ 2,766.3 Mn
Geographies covered:	North America: U.S. and Canada Latin America: Brazil, Argentina, Mexico, and Rest of Latin America Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific Middle East: GCC Countries, Israel, and Rest of Middle East Africa: South Africa, North Africa, and Central Africa
Segments covered:	By Form: Solid, Liquid By Application: Food and Beverages, Dietary Supplements, Animal Feed, Pharmaceuticals, Others By Distribution Channel: Online Pharmacy, Retail Pharmacy, Hospital Pharmacy, Supermarket/Hypermarket
Companies covered:	DuPont Nutrition (International Flavors & Fragrances Inc.), BIOPROX, Biena Inc., Chr. Hansen Holding A/S, Nebraska Cultures, Meteoric Biopharmaceuticals Pvt. Ltd., Nestlé, Lallemand Inc., and Fido Pharma Pvt. Ltd.
Growth Drivers:	Increasing prevalence of gastrointestinal diseases Increasing awareness regarding the health benefits of probiotics
Restraints & Challenges:	Lack of proper regulations in the probiotics industry

Figure 2. Global Lactobacillus Acidophilus Probiotics Market Share (%), by Region, 2022

Global Lactobacillus Acidophilus Probiotics Market– Impact of Coronavirus (COVID-19) Pandemic

Since the COVID-19 virus outbreak in December 2019, the disease has spread to over 100 countries across the globe and the World Health Organization declared it a public health emergency on January 30, 2020.

COVID-19 has affected the economy in three main ways: by directly affecting the production and demand of drugs and vaccines, by creating disruptions in distribution channels, and through its financial impact on firms and financial markets. Due to nationwide lockdowns, several countries, such as China, India, Saudi Arabia, UAE, Egypt, and others, faced problems with regard to the transportation of drugs and vaccines from one place to another.

However, COVID-19 had a positive impact on the global lactobacillus acidophilus probiotics market, as demand for immunity-boosting food products and supplements increased. Probiotics are well known for their immunity-boosting properties, as they offer robust protection against gastrointestinal pathogens and also promote the production of natural antibodies in the body.

Global Lactobacillus Acidophilus Probiotics Market: Key Developments

In March 2018, Danone, a France-based multinational food-products corporation based in Paris, entered into a strategic partnership with Yakult, a Japan-based sweetened probiotic milk beverage company, to sell 14% of Danone’s stake in Yakult for US$ 1.48 billion. This partnership will promote activities and research towards manufacturing strains with low side effects and high-performance efficacy augmenting lactobacillus acidophilus probiotics market growth.

Global Lactobacillus Acidophilus Probiotics Market: Restraint

The lack of proper regulations in the probiotics industry is expected to hinder the market growth. Moreover, probiotics require proper storage facilities, as they are highly sensitive organisms and may easily get weakened by various environmental factors. Moreover, most of the probiotics are unstable at room temperature. All these factors are expected to hamper the market growth.

Global Lactobacillus Acidophilus Probiotics Market- Key Players

Major players operating in the global lactobacillus acidophilus probiotics market include DuPont Nutrition (International Flavors & Fragrances Inc.), BIOPROX, Biena Inc., Chr. Hansen Holding A/S, Nebraska Cultures, Meteoric Biopharmaceuticals Pvt. Ltd., Nestlé, Lallemand Inc., and Fido Pharma Pvt. Ltd.

Table of Content

Table of Contents

*Browse 28 market data tables and 31 figures on “Lactobacillus Acidophilus Probiotics Market” - Global forecast to 2030

Segmentation

Detailed Segmentation:

- Frequently Asked Questions -

What is the current market size and compound annual growth rate (CAGR) of the global lactobacillus acidophilus probiotics market during the forecast period (2022-2030)?

Global lactobacillus acidophilus probiotics market is estimated to be valued at US$ 1,499.7 million in 2022 and is expected to exhibit a CAGR of 8.0 % between 2022 and 2030.

What are the major factors driving the market growth?

Factors such as the increasing prevalence of gastrointestinal diseases and increasing awareness about the health benefits of probiotics are expected to drive the market.

Which is the leading application segment in the market?

Food and Beverages is the leading application segment in the market.

What are the key factors hampering growth of the market?

The major factors hampering the growth of the market include lack of proper regulations in the probiotics industry.

Which are the major players operating in the market?

Major players operating in the market include DuPont Nutrition (International Flavors & Fragrances Inc.), BIOPROX, Biena Inc., Chr. Hansen Holding A/S, Nebraska Cultures, Meteoric Biopharmaceuticals Pvt. Ltd., Nestlé, Lallemand Inc., and Fido Pharma Pvt. Ltd.